Inicio › Adenocarcinoma de esófago › Massachusetts › Boston
Ensayos clínicos de Adenocarcinoma de esófago en Boston, MA
13 estudios para Adenocarcinoma de esófago buscan participantes en centros de Boston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
ReclutandoFase 1
- Dana-Farber Cancer Institute, Boston
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
ReclutandoFase 3
- Boston Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
ReclutandoFase 1
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
ReclutandoFase 1/2
- Dana-Farber Cancer Institute, Boston
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
ReclutandoFase 2
- Massachusetts General Hospital, Boston
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Reclutando
- Beth Israel Deaconess Medical Center, Boston
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
ReclutandoFase 3
- Research Site, Boston
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
ReclutandoFase 1
- Normunity Investigational Site, Boston
- Normunity Investigational Site, Boston
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- Massachusetts General Hospital, Boston
- Brigham & Women's Hospital, Boston
- Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
- y 2 más
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
ReclutandoEstudio observacional
- Dana-Farber Cancer Institute, Boston
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Research Site, Boston
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
ReclutandoFase 2
- I-Mab Site 1002, Boston
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Mass General Hospital, Boston
Ensayos de Adenocarcinoma de esófago en otras ciudades
- New York City, NY18 estudios
- Houston, TX12 estudios
- Nashville, TN11 estudios
- Arlington, VA11 estudios
- Durham, NC10 estudios
- Rochester, MN9 estudios
- St. Louis, MO9 estudios
- Jacksonville, FL9 estudios
- Baldwin Park, CA9 estudios
- Queens, NY9 estudios
- Los Angeles, CA9 estudios
- Pittsburgh, PA8 estudios
Otros estudios en Boston
- Cáncer de seno112 estudios
- Cáncer de pulmón de células no pequeñas90 estudios
- Cáncer (todos los tipos)85 estudios
- Cáncer metastásico63 estudios
- Cáncer del colon y del recto63 estudios
- Cáncer de pulmón62 estudios
- Cáncer de ovario61 estudios
- Cáncer de próstata59 estudios
- Depresión52 estudios
- Cáncer de endometrio50 estudios
- Fallo cardíaco44 estudios
- Leucemia mielógena aguda44 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.